Molecular cancer therapy: Epigallocatechin 3-Gallate (EGCG), the major component of green tea, induces the expression of p53 homologue p63 via down regulation of its target gene, 3/February/2014, 21.13

Therapeutic insights into the targeting of invasiveness of cancer cells: δ-tocotrienol(Vitamin-E) suppresses the expression of UDP-N-acetyl-α-D-galactosamine:polypeptide N-acetylgalactosaminyltransferase 7 (GALNT7) via up regulation of its target gene, 3/February/2014, 21.03 am
February 3, 2014
Therapeutic insights into the targeting of invasiveness of cancer cells: Tumor suppressor p53 suppresses the expression of UDP-N-acetyl-α-D-galactosamine:polypeptide N-acetylgalactosaminyltransferase 7 (GALNT7) via up regulation of its target gene, 3/February/2014, 21.18
February 3, 2014
Show all

Idea Proposed/Formulated byDr L Boominathan Ph.D.

Web: http://genomediscovery.org

Terms & Conditions apply http://genomediscovery.org/registration/terms-and-conditions/

To citeBoominathan, Molecular cancer therapy: Epigallocatechin 3-Gallate (EGCG), the major component of green tea, induces the expression of p53 homologue p63 via down regulation of its target gene, 3/February/2014, 21.13, Genome-2-Bio-Medicine Discovery center (GBMD), http://genomediscovery.org

Courtesy: When you cite drop us a line at info@genomediscovery.org

Comments are closed.